Joana Silva-Balca
Coimbra, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Cellular and molecular mechanisms of glioblastoma malignancy: Implications in resistance and therapeutic strategies.
Journal: Seminars in cancer biology
Published: June 13, 2018
Microglia/Astrocytes-Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors.
Journal: Frontiers in cellular neuroscience
Published: May 20, 2018
Nucleolin is expressed in patient-derived samples and glioblastoma cells, enabling improved intracellular drug delivery and cytotoxicity.
Journal: Experimental cell research
Published: May 03, 2018
GBM-Derived Wnt3a Induces M2-Like Phenotype in Microglial Cells Through Wnt/β-Catenin Signaling.
Journal: Molecular neurobiology
Published: April 09, 2018
Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: March 19, 2017
Glioblastoma entities express subtle differences in molecular composition and response to treatment.
Glioblastoma entities express subtle differences in molecular composition and response to treatment.
Journal: Oncology reports
Published: January 11, 2017
The Expression of Connexins and SOX2 Reflects the Plasticity of Glioma Stem-Like Cells.
Journal: Translational oncology
Published: December 29, 2016
Gliomas and the vascular fragility of the blood brain barrier.
Journal: Frontiers in cellular neuroscience
Published: July 21, 2014
Tamoxifen in combination with temozolomide induce a synergistic inhibition of PKC-pan in GBM cell lines.
Journal: Biochimica et biophysica acta
Published: April 07, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026